---
title: "Viridian Therapeutics Announces Pricing of Upsized Concurrent Public Offerings of 1.75% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $350.0 Million | VRDN Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285477473.md"
description: "Viridian Therapeutics Announces Pricing of Upsized Concurrent Public Offerings of 1.75% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $350.0 Million | VRDN Stock News"
datetime: "2026-05-06T19:15:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285477473.md)
  - [en](https://longbridge.com/en/news/285477473.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285477473.md)
---

# Viridian Therapeutics Announces Pricing of Upsized Concurrent Public Offerings of 1.75% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $350.0 Million | VRDN Stock News

Viridian Therapeutics Announces Pricing of Upsized Concurrent Public Offerings of 1.75% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $350.0 Million | VRDN Stock News

### Related Stocks

- [VRDN.US](https://longbridge.com/en/quote/VRDN.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)

## Related News & Research

- [Viridian Therapeutics (VRDN) Expected to Announce Quarterly Earnings on Tuesday](https://longbridge.com/en/news/284408334.md)
- [Stock Traders Purchase Large Volume of Put Options on Viridian Therapeutics (NASDAQ:VRDN)](https://longbridge.com/en/news/281778939.md)
- [Viridian Therapeutics (NASDAQ:VRDN) Price Target Lowered to $40.00 at Truist Financial](https://longbridge.com/en/news/271968590.md)
- [Wells Fargo & Company Forecasts Strong Price Appreciation for Viridian Therapeutics (NASDAQ:VRDN) Stock](https://longbridge.com/en/news/274669588.md)
- [BUZZ-Viridian Therapeutics eases after unveiling stock, convertible offerings](https://longbridge.com/en/news/285404209.md)